SouthState Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.5M Sell
32,467
-2,013
-6% -$662K 0.44% 68
2025
Q4
$12.1M Sell
34,480
-1,259
-4% -$425K 0.54% 57
2025
Q3
$11.5M Sell
35,739
-1,620
-4% -$504K 0.53% 56
2025
Q2
$14.5M Buy
37,359
+219
+0.6% +$88.1K 0.64% 47
2025
Q1
$16.2M Sell
37,140
-1,439
-4% -$578K 0.74% 43
2024
Q4
$14.2M Sell
38,579
-1,902
-5% -$796K 0.93% 31
2024
Q3
$21.1M Sell
40,481
-890
-2% -$475K 1.45% 20
2024
Q2
$22.4M Sell
41,371
-756
-2% -$400K 1.64% 13
2024
Q1
$21.8M Buy
42,127
+226
+0.5% +$112K 1.7% 11
2023
Q4
$19.8M Sell
41,901
-722
-2% -$334K 1.69% 13
2023
Q3
$18.6M Sell
42,623
-649
-1% -$294K 1.76% 14
2023
Q2
$19.2M Sell
43,272
-1,164
-3% -$537K 1.72% 14
2023
Q1
$20.4M Sell
44,436
-7,185
-14% -$3.42M 1.89% 9
2022
Q4
$26.5M Sell
51,621
-530
-1% -$269K 2.45% 5
2022
Q3
$23.7M Sell
52,151
-519
-1% -$248K 2.36% 7
2022
Q2
$25.4M Sell
52,670
-591
-1% -$292K 2.39% 6
2022
Q1
$26.2M Sell
53,261
-664
-1% -$304K 2.08% 8
2021
Q4
$25M Sell
53,925
-1,267
-2% -$533K 1.95% 8
2021
Q3
$20.6M Buy
55,192
+107
+0.2% +$40.7K 1.73% 11
2021
Q2
$21M Sell
55,085
-394
-0.7% -$151K 1.81% 11
2021
Q1
$19.9M Sell
55,479
-163
-0.3% -$52.4K 1.86% 10
2020
Q4
$17.9M Sell
55,642
-4,254
-7% -$1.31M 1.76% 12
2020
Q3
$16.1M Sell
59,896
-1,099
-2% -$296K 1.68% 13
2020
Q2
$16M Sell
60,995
-370
-0.6% -$98.7K 1.96% 11
2020
Q1
$13.9M Sell
61,365
-815
-1% -$222K 2.07% 10
2019
Q4
$18.8M Buy
62,180
+923
+2% +$254K 2.16% 5
2019
Q3
$14.7M Sell
61,257
-3,992
-6% -$1.09M 1.84% 9
2019
Q2
$18.4M Sell
65,249
-4,663
-7% -$1.27M 2.12% 6
2019
Q1
$20.1M Sell
69,912
-1,368
-2% -$396K 2.06% 5
2018
Q4
$18.7M Buy
71,280
+8,028
+13% +$2.21M 2.16% 3
2018
Q3
$17.3M Buy
63,252
+7,420
+13% +$1.93M 1.78% 6
2018
Q2
$13.3M Buy
55,832
+113
+0.2% +$26.2K 1.49% 9
2018
Q1
$12.2M Buy
55,719
+1,800
+3% +$423K 1.41% 11
2017
Q4
$12.1M Buy
53,919
+1,743
+3% +$371K 1.31% 12
2017
Q3
$9.91K Buy
52,176
+2,854
+6% +$543K 1.11% 21
2017
Q2
$9.28M Buy
49,322
+4,817
+11% +$866K 1.19% 20
2017
Q1
$7.36M Buy
44,505
+8,156
+22% +$1.3M 0.96% 36
2016
Q4
$5.23M Buy
36,349
+12,256
+51% +$1.64M 0.75% 48
2016
Q3
$3.02M Buy
24,093
+1,186
+5% +$153K 0.46% 73
2016
Q2
$3.01M Buy
22,907
+1,194
+5% +$163K 0.45% 76
2016
Q1
$3.02M Sell
21,713
-440
-2% -$58.8K 0.47% 75
2015
Q4
$3.09M Sell
22,153
-575
-3% -$79.2K 0.48% 75
2015
Q3
$3.18M Buy
22,728
+350
+2% +$52.6K 0.49% 76
2015
Q2
$3.67M Sell
22,378
-380
-2% -$60.7K 0.51% 69
2015
Q1
$3.51M Sell
22,758
-670
-3% -$95.4K 0.5% 68
2014
Q4
$2.94M Sell
23,428
-1,090
-4% -$135K 0.46% 72
2014
Q3
$2.93M Sell
24,518
-927
-4% -$106K 0.45% 71
2014
Q2
$2.74M Sell
25,445
-265
-1% -$27.3K 0.45% 74
2014
Q1
$2.56M Sell
25,710
-410
-2% -$37.1K 0.41% 80
2013
Q4
$2.41M Hold
26,120
0.4% 79
2013
Q3
$2.18M Buy
26,120
+1,420
+6% +$122K 0.41% 81
2013
Q2
$2.02M Buy
+24,700
New +$1.85M 0.43% 74

Other funds holding ELV

SouthState Corp's ELV Position: Q1 2026 in Review

SouthState Corp reduced its Elevance Health (ELV) stake by 5.8% in Q1 2026, selling an estimated $662K and leaving 32,467 shares worth $9.5M. The position accounts for 0.44% of the portfolio, ranked #68.

SouthState Corp first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.5M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • SouthState Corp held 32,467 shares of Elevance Health worth $9.5M as of Q1 2026.
  • SouthState Corp sold 2,013 Elevance Health shares in Q1 2026, an estimated $662K.
  • Elevance Health made up 0.44% of SouthState Corp's portfolio in Q1 2026, its #68 holding.
  • SouthState Corp first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Elevance Health position peaked at $26.5M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.